Galapagos sells CAR-T pipeline to Armed Cell Therapeutics in €8M deal
Lakefront Biotherapeutics sold its preclinical CAR-T portfolio to Armed Cell Therapeutics, ending a long wind-down of its cell therapy unit.
Therapeutics, diagnostics and evidence shaping cancer care.
Therapeutics, diagnostics and evidence shaping cancer care.